Open AccessThe cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Author(s) -
Greene Stephen J.,
Gheorghiade Mihai,
Borlaug Barry A.,
Pieske Burkert,
Vaduganathan Muthiah,
Burnett John C.,
Roessig Lothar,
Stasch JohannesPeter,
Solomon Scott D.,
Paulus Walter J.,
Butler Javed
Publication year - 2013
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.113.000536
Subject(s) - medicine , heart failure , ejection fraction , cardiology , heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is a growing public health problem that accounts for approximately half of all prevalent heart failure (HF).[1][1]–[2][2] Once believed to carry a favorable prognosis compared with HF and reduced ejection fraction (HFrEF), contemporary data